Tuesday, 10 September 2013

Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey.

Plants traditionally used in age-related brain disorders (dementia): an ethanopharmacological survey.
Pharm Biol. 2013 Apr;51(4):492-523
Authors: Natarajan S, Shunmugiah KP, Kasi PD
Abstract
CONTEXT: Epidemiological studies have shown that despite mortality due to communicable diseases, poverty and human conflicts, the incidence of dementia increases in the developing world in tandem with the ageing population. Although some FDA approved drugs are available for the treatment of dementia, the outcomes are often unsatisfactory. In traditional practices of medicine, numerous plants have been used to treat cognitive disorders, including neurodegenerative diseases such as Alzheimer's disease (AD) and other memory-related disorders. In western medicine most of the drugs used for the treatment of neurodegenerative disorders are derived from plant sources.
OBJECTIVE: This article reviews plants and their active constituents that have been used for their reputed cognitive-enhancing and antidementia effects.

METHODS: A literature survey in Science Direct, Pubmed, and Google Scholar was performed to gather information regarding drug discovery from plants sources for the treatment of congnitive disorders and dementia.
RESULTS: More than forty herbal remedies were identified with cholinesterase inhibitory, anti-inflammatory, or antioxidant activities. Bioactive compounds include alkaloids, flavonoids, steroids, saponins, terpenoids, and essential oils. About eleven herbal plants with multipotent activity against AD are discussed.
CONCLUSION: Literature surveys show that most of the research has been conducted on herbal remedies effect on cholinesterase inhibitory and antioxidant activities. Studies regarding the effect of herbal drugs on β-secretase inhibitory activity and antiaggregation property are lacking. This review provides leads for identifying potential new drugs from plant sources for the treatment of neurodegenerative disorders